Paul Sabatier University-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2019

  1. Oral phenelzine treatment mitigates metabolic disturbances in mice fed a high-fat diet

    Journal of Pharmacology and Experimental Therapeutics, Vol. 371, Núm. 2, pp. 555-566

2018

  1. Metabolic effects of oral phenelzine treatment on high-sucrose-drinking mice

    International Journal of Molecular Sciences, Vol. 19, Núm. 10

2015

  1. Novel strategies for preventing diabetes and obesity complications with natural polyphenols

    Current Medicinal Chemistry, Vol. 22, Núm. 1, pp. 150-164

2014

  1. Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice

    European Journal of Nutrition, pp. 1625-1635

2013

  1. 5-hydroxytryptamine actions in adipocytes: Involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation

    Journal of Neural Transmission, Vol. 120, Núm. 6, pp. 919-926

  2. Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells

    Journal of Physiology and Biochemistry, Vol. 69, Núm. 3, pp. 585-593